DSpace Repository

Discovery and Characterization of an Endogenous CXCR4 Antagonist

Show simple item record

dc.contributor.advisor Timo, Burster
dc.contributor.author O., Zirafi
dc.contributor.author K-A., Kim
dc.contributor.author L., Ständker
dc.contributor.author K. B., Mohr
dc.contributor.author D., Sauter
dc.contributor.author A., Heigele
dc.contributor.author S. F., Kluge
dc.contributor.author E., Wiercinska
dc.contributor.author D., Chudziak
dc.contributor.author R., Richter
dc.contributor.author B., Moepps
dc.contributor.author P., Gierschik
dc.contributor.author V., Vas
dc.contributor.author H., Geiger
dc.contributor.author M., Lamla
dc.contributor.author T., Weil
dc.contributor.author T., Burster
dc.contributor.author A., Zgraja
dc.contributor.author F., Daubeuf
dc.contributor.author N., Frossard
dc.contributor.author Timo, Burster
dc.date.accessioned 2018-08-20T09:13:59Z
dc.date.available 2018-08-20T09:13:59Z
dc.date.issued 2015-05-05
dc.identifier.citation Zirafi, O. , Kim, K-A. , Ständker, L. , Mohr, K. B. , Sauter, D. , Heigele, A. , Kluge, S. F. , Wiercinska, E. , Chudziak, D. , Richter, R. , Moepps, B. , Gierschik, P. , Vas, V. , Geiger, H. , Lamla, M. , Weil, T. , Burster, T. , Zgraja, A. , Daubeuf, F. , Frossard, N. 2015. Discovery and Characterization of an Endogenous CXCR4 Antagonist. Cell Reports. 11, 5, p. 737-47 11 p. en_US
dc.identifier.uri http://nur.nu.edu.kz/handle/123456789/3392
dc.description.abstract CXCL12-CXCR4 signaling controls multiple physiological processes and its dysregulation is associated with cancers and inflammatory diseases. To discover as-yet-unknown endogenous ligands of CXCR4, we screened a blood-derived peptide library for inhibitors of CXCR4-tropic HIV-1 strains. This approach identified a 16 amino acid fragment of serum albumin as an effective and highly specific CXCR4 antagonist. The endogenous peptide, termed EPI-X4, is evolutionarily conserved and generated from the highly abundant albumin precursor by pH-regulated proteases. EPI-X4 forms an unusual lasso-like structure and antagonizes CXCL12-induced tumor cell migration, mobilizes stem cells, and suppresses inflammatory responses in mice. Furthermore, the peptide is abundant in the urine of patients with inflammatory kidney diseases and may serve as a biomarker. Our results identify EPIX4 as a key regulator of CXCR4 signaling and introduce proteolysis of an abundant precursor protein as an alternative concept for chemokine receptor regulation. en_US
dc.language.iso en en_US
dc.publisher Cell Reports en_US
dc.rights Attribution-NonCommercial-ShareAlike 3.0 United States *
dc.rights.uri http://creativecommons.org/licenses/by-nc-sa/3.0/us/ *
dc.title Discovery and Characterization of an Endogenous CXCR4 Antagonist en_US
dc.type Article en_US
workflow.import.source science


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States